These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16835496)

  • 1. [A gastric stromal tumor (GIST) with a prolonged partial response to a reduced dose of imatinib mesilate].
    Nakatani K; Tanabe S; Nishimura K; Shimoda T; Azuma M; Katada C; Sasaki T; Higuchi K; Koizumi W; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):997-1000. PubMed ID: 16835496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent gastrointestinal stromal tumor of the stomach with complete response to imatinib mesilate].
    Aoyama T; Saeki H; Samejima J; Fujii K; Ishikawa Y; Kawamoto M; Fujisawa J; Matsukawa H; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):975-8. PubMed ID: 19542718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of low-dose and long-term administration of imatinib in patients with liver metastases of rectal GIST and GIST of stomach].
    Kimura O; Yamamoto O; Hisamitsu K; Yamane N; Hamazoe R
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2285-7. PubMed ID: 21224549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Imatinib mesylate alone for refractory advanced gastrointestinal stromal tumor].
    Shen L; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):697-9. PubMed ID: 15777512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of recurrent gastrointestinal stromal tumor with complete response from treatment with reduced dose of imatinib mesylate].
    Toyokawa T; Yamashita Y; Yamamoto A; Shimizu S; Inoue T; Ikehara T; Sakashita K; Kanehara I; Teraoka H; Nishiguchi Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1723-5. PubMed ID: 23152028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent GIST successfully treated with low-dose imatinib mesilate].
    Hanada N; Kawamura Y; Taneda T; Yoshida Y; Osako T; Inoue K
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):799-801. PubMed ID: 16770100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric antral vascular ectasia in a patient with GIST after treatment with imatinib: case report and literature review.
    Saad Aldin E; Mourad F; Tfayli A
    Jpn J Clin Oncol; 2012 May; 42(5):447-50. PubMed ID: 22422898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
    Le Cesne A; Blay JY; Bui BN; Bouché O; Adenis A; Domont J; Cioffi A; Ray-Coquard I; Lassau N; Bonvalot S; Moussy A; Kinet JP; Hermine O
    Eur J Cancer; 2010 May; 46(8):1344-51. PubMed ID: 20211560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a case.
    Ando Y; Tsunoda T; Beck Y; Takayama T; Tahara H
    Surg Today; 2005; 35(2):157-60. PubMed ID: 15674500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of recurrent GIST successfully treated with imatinib mesylate at 100mg/day].
    Hanada N; Kawata K; Okamura S; Tomiyama N; Hori K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):803-5. PubMed ID: 23863663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
    Blay JY; Le Cesne A; Ray-Coquard I; Bui B; Duffaud F; Delbaldo C; Adenis A; Viens P; Rios M; Bompas E; Cupissol D; Guillemet C; Kerbrat P; Fayette J; Chabaud S; Berthaud P; Perol D
    J Clin Oncol; 2007 Mar; 25(9):1107-13. PubMed ID: 17369574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor.
    Gronchi A; Blay JY; Trent JC
    Cancer; 2010 Apr; 116(8):1847-58. PubMed ID: 20166214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatic metastasis from gastric GIST radically resected after imatinib mesylate therapy-a case report].
    Kittaka H; Yamada T; Goto K; Ogawa H; Shingai T; Motoori M; Takahashi H; Kishi K; Noura S; Miyashiro I; Ohue M; Ohigashi H; Yano M; Ishikawa O
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2508-10. PubMed ID: 22202429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complete response achieved in a case of gastric gastrointestinal stromal tumor by administration of imatinib mesilate with concurrent relatively high-dose steroid therapy to control side effects].
    Tsukada Y; Tauchi K; Nakamura M; Kishimoto H; Yoshifuku S; Otagiri N; Sasahara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2181-4. PubMed ID: 21084823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate treatment for advanced gastrointestinal stromal tumor: a pilot study focusing on patients experiencing sole liver metastasis after a prior radical resection.
    Zhu J; Wang Y; Hou M; Li HY; Zhang J
    Oncology; 2007; 73(5-6):324-7. PubMed ID: 18497504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of Giant GIST of the stomach successfully treated with imatinib mesylate neoadjuvant therapy and followed postoperatively].
    Okuda H; Tanaka H; Ueno M; Shitani M; Nasuno M; Suzuki C; Nishimura S; Kimura H; Yonezawa K; Abe T; Yoshida Y; Kawabata M
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1941-4. PubMed ID: 16282731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate.
    Rutkowski P; Nowecki Z; Nyckowski P; Dziewirski W; Grzesiakowska U; Nasierowska-Guttmejer A; Krawczyk M; Ruka W
    J Surg Oncol; 2006 Mar; 93(4):304-11. PubMed ID: 16496358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant therapy with imatinib mesilate for gastrointestinal stromal tumor of the stomach before subsequent successful surgical resection].
    Yamamoto K; Imamura H; Furukawa H; Kishimoto T; Miyazaki Y; Ohshiro R; Tatsuta M; Ohsato H; Fukunaga M; Nakayama T; Fujimi S; Takemoto H; Kondo M; Kamigaki S; Ohta K; Nakata Y
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1875-7. PubMed ID: 17212133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
    Wan DS; Wu XJ; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Ding PR
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3064-7. PubMed ID: 17288838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of gastric gastrointestinal stromal tumor operated after low-dose chemotherapy with imatinib mesylate].
    Hori K; Hanada N; Kusano S; Tsurumoto Y; Sakashita N; Uchino R
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1749-51. PubMed ID: 18931581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.